Rezolute, Inc.’s Post

Comorbidities may affect a participant's response to treatment, intensify side effects, or interact with experimental medications. All of these effects may cause unfavorable outcomes or change how successful a treatment is administered. Read our latest BioPharma Dive article and learn why acknowledging comorbidities in trial design is essential for successful outcomes: http://spr.ly/604393wJT #PharmaResearchServices #ClinicalTrials

🔬 Understand therapeutic monitoring for ALL/LBL patients on asparaginase therapies. Recognize associated toxicities and select the best treatment approach. Manage treatment and communicate effectively with patients and families 💬 http://ms.spr.ly/6041YX171

🔬 Understand therapeutic monitoring for ALL/LBL patients on asparaginase therapies. Recognize associated toxicities and select the best treatment approach. Manage treatment and communicate effectively with patients and families 💬 http://ms.spr.ly/6043Y9EMc

What an interesting read on the rise of patient-led clinical research in rare diseases! Check out our latest blog to learn about the latest shift in rare clinical trials and how patient organizations have helped advance drug development efforts: https://bit.ly/40Ljgao

What an interesting read on the rise of patient-led clinical research in rare diseases! Check out our latest blog to learn about the latest shift in rare clinical trials and how patient organizations have helped advance drug development efforts: https://bit.ly/3Odedbv

Clinical trial participants often require regular monitoring to assess drug efficacy, but frequent blood draws can reduce compliance and increase participant discomfort. Invasive testing can discourage participants from staying in clinical trials, potentially compromising the quality and quantity of the data collected. Metabolic Solutions’ breath tests are non-invasive and easily repeatable, making them ideal for clinical trials requiring regular, frequent assessments.   Our tests provide high-quality data without causing discomfort, helping ensure participant retention and data integrity. Learn more at https://lnkd.in/er_X2ub6 #LiverHealth #LiverDiseaseResearch #NASH #ClinicalTrials #LiverCancer #LiverCare #PharmaResearch

What an interesting read on the rise of patient-led clinical research in rare diseases! Check out our latest blog to learn about the latest shift in rare clinical trials and how patient organizations have helped advance drug development efforts: https://bit.ly/4hx3lTd

What an interesting read on the rise of patient-led clinical research in rare diseases! Check out our latest blog to learn about the latest shift in rare clinical trials and how patient organizations have helped advance drug development efforts: https://bit.ly/4hEVjrh

What an interesting read on the rise of patient-led clinical research in rare diseases! Check out our latest blog to learn about the latest shift in rare clinical trials and how patient organizations have helped advance drug development efforts: https://bit.ly/48U3ix3

What an interesting read on the rise of patient-led clinical research in rare diseases! Check out our latest blog to learn about the latest shift in rare clinical trials and how patient organizations have helped advance drug development efforts: https://bit.ly/48Q3tZY